Medtronic plc
MDT
$92.70
-$1.36-1.45%
| Weiss Ratings | MDT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | B | |||
| Rating Factors | MDT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Good | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | MDT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.40 | |||
| Price History | MDT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 2.43% | |||
| 30-Day Total Return | 5.50% | |||
| 60-Day Total Return | 11.10% | |||
| 90-Day Total Return | 1.31% | |||
| Year to Date Total Return | 15.53% | |||
| 1-Year Total Return | 12.03% | |||
| 2-Year Total Return | 20.93% | |||
| 3-Year Total Return | -4.22% | |||
| 5-Year Total Return | 7.82% | |||
| 52-Week High % Change | -1.58% | |||
| 52-Week Low % Change | 23.83% | |||
| Price | MDT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $95.57 | |||
| 52-Week Low Price | $75.96 | |||
| 52-Week Low Price (Date) | Jul 09, 2024 | |||
| 52-Week High Price (Date) | Mar 04, 2025 | |||
| Valuation | MDT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 120.64B | |||
| Enterprise Value | 139.52B | |||
| Price/Earnings (TTM) | 28.62 | |||
| Earnings Per Share (TTM) | 3.29 | |||
| Earnings Per Share Growth | 4.68% | |||
| Price/Earnings To Growth | 6.11 | |||
| Price/Sales (TTM) | 3.64 | |||
| Price/Book (Q) | 2.44 | |||
| Enterprise Value/Revenue (TTM) | 4.20 | |||
| Price | $92.68 | |||
| Enterprise Value/EBITDA (TTM) | 14.81 | |||
| Enterprise Value/EBIT | 20.69 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | MDT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.29B | |||
| Dividend Yield | 2.97% | |||
| Div. Per Share (Most Recent) | $0.70 | |||
| Dividend Per Share (TTM) | $2.79 | |||
| Payout Ratio (TTM) | 84.62% | |||
| Dividend Per Share (Most Recent) | $0.70 | |||
| Company Info | MDT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 353 1 438 1700 | |||
| Address | -- | |||
| Website | www.medtronic.com | |||
| Country | Ireland | |||
| Year Founded | 1949 | |||
| Profitability | MDT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 20.31% | |||
| Profit Margin | 12.83% | |||
| Management Effectiveness | MDT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 4.66% | |||
| Return on Equity | 8.44% | |||
| Income Statement | MDT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 33.20B | |||
| Total Revenue (TTM) | 33.20B | |||
| Revenue Per Share | $25.81 | |||
| Gross Profit (TTM) | 21.78B | |||
| EBITDA (TTM) | 9.42B | |||
| EBIT (TTM) | 6.74B | |||
| Net Income (TTM) | 4.26B | |||
| Net Income Avl. to Common (TTM) | 4.26B | |||
| Total Revenue Growth (Q YOY) | 2.51% | |||
| Earnings Growth (Q YOY) | -2.54% | |||
| EPS Diluted (TTM) | 3.29 | |||
| EPS Diluted Growth (Q YOY) | 1.92% | |||
| Balance Sheet | MDT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 7.92B | |||
| Cash Per Share (Q) | $6.16 | |||
| Total Current Assets (Q) | 22.51B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 49.62B | |||
| Current Ratio (Q) | 1.901 | |||
| Book Value Per Share (Q) | $38.49 | |||
| Total Assets (Q) | 89.97B | |||
| Total Current Liabilities (Q) | 11.84B | |||
| Total Debt (Q) | 26.61B | |||
| Total Liabilities (Q) | 40.36B | |||
| Total Common Equity (Q) | 49.39B | |||
| Cash Flow | MDT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -2.14B | |||
| Cash from Financing (TTM) | -5.38B | |||
| Net Change in Cash (TTM) | -383.00M | |||
| Levered Free Cash Flow (TTM) | 5.08B | |||
| Cash from Operations (TTM) | 7.29B | |||
